Skip to main content
letter
. 2019 Apr 29;7:63. doi: 10.1186/s40478-019-0721-7

Table 1.

Genetic alterations identified by NGS

Surgery 1 Infiltrating glioma, WHO grade II Surgery 2 Glioblastoma, WHO grade IV
Patient 1 FGFR3 p.K650 T (MAF = 4%)
FGFR3-TACC3 fusion		 FGFR3 p.K650 T (MAF = 29%)
NF1 p.F443C
TERT c.-124C > T
FGFR3-TACC3 (COSF1353)
N/A Surgery 1 Glioblastoma, WHO grade IV
Patient 2 N/A FGFR3 p.K650 T (MAF = 12%)
TERT c.-146C > T
FGFR3-TACC3 (COSF1348)